Clinical Trial Update: Combination Chemotherapy (FLAG-Ida) Followed Immediately by Reduced-Intensity Total Body Radiation Therapy and Donor Hematopoietic Cell Transplant for the Treatment of Adults Age 60 and Older With Newly Diagnosed Adverse-Risk Acute Myeloid Leukemia or Other High-Grade Myeloid Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating FLAG-Ida chemotherapy followed by reduced-intensity total body irradiation and donor hematopoietic cell transplantation in adu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Leukemia of Ambiguous Lineage
• Myelodysplastic Syndrome
• Myelomonocytic Leukemia

Drugs mentioned

• CYTARABINE (CYTARABINE)
• Filgrastim (filgrastim)
• Fludarabine (Fludarabine)
• Idarubicin (idarubicin)

Snippet

Sponsor: Fred Hutchinson Cancer Center | Conditions: Acute Leukemia of Ambiguous Lineage, Acute Myeloid Leukemia | Phase 2 | Status: RECRUITING